DISTAL ESOPHAGUS ADENOCARCINOMA

Clinical trials for DISTAL ESOPHAGUS ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new DISTAL ESOPHAGUS ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for DISTAL ESOPHAGUS ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Experimental combo targets Hard-to-Treat esophageal cancer

Disease control Ongoing

This early-stage trial tested a drug called adavosertib combined with radiation for people with advanced esophageal or stomach cancer that cannot be removed by surgery. The goal was to find the safest dose and see how well the combination works. Only 4 people took part, so result…

Matched conditions: DISTAL ESOPHAGUS ADENOCARCINOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated May 17, 2026 04:17 UTC

DISTAL ESOPHAGUS ADENOCARCINOMA

Get alerted when new DISTAL ESOPHAGUS ADENOCARCINOMA trials appear

Experimental combo targets Hard-to-Treat esophageal cancer